top of page

Case Study: How a Therapeutics Company Built an NGS Core Service That Scaled to Serve 60+ Scientists

Writer: Karchem Consulting
Karchem Consulting
19 hours ago
2 min read

Client

Clinical Stage Therapeutics Company

Service

NGS core lab workflow optimization and Benchling/LIMS integrations

Key Results
  • 7 Instruments Integrated into several fully tracked workflows

  • 60+ Scientists Leveraging one standardized submission process to an 8-person team

  • Forecast-Ready Planning & Resource Allocation: Sequencer usage, run volumes, resourcing, and budgets can now be accurately forecasted

A clinical-stage therapeutics company was standing up a company-wide next-generation sequencing (NGS) core service, but were struggling to reliably track samples from intake through sequencing and into analysis. A small team of scientists handled requests from animal studies, cell-based studies, and other R&D work, and were constantly running into copy-paste errors, broken handoffs due to lack of standardization, and hard-to-query data from incorrectly configured relationships between intermediate samples. Working with Karchem, this company optimized the end-to-end workflow, introduced unique sample identifiers carried across the full analysis pipeline, and built automated, error-free sample sheets for a variety of sequencers including MiSeq, NextSeq, and NovaSeqs from data entered in Benchling. The result was more samples processed, standardized submissions from 60+ scientists across the organization, and reliable forecasting for runs, budget, and project timelines.


Introduction

Our client is a clinical-stage therapeutics company building an internal NGS core service to support research across the organization. Their core team of eight scientists prepares and submits samples for sequencing on behalf of internal groups, animal studies, cell-based studies, and discovery R&D, then routes results to a separate analysis team. Because sequencing touches nearly every research function, the core service needed to operate as reliable shared infrastructure, not a bottleneck.


Challenge

The new NGS core service had no reliable way to track a sample from intake to sequencing to analysis. Many tasks were manual, and a broken data setup in Benchling meant results couldn't always be traced back to the right sample.

  • Sample tracking was slow and manual

  • Copy-pasting caused repeated errors

  • Work was fragmented across teams and hand-offs

  • Benchling relationships were set up incorrectly, so sample lineage broke

  • Sample-level tracking limited scope and scalability



Solution / Approach

Karchem rebuilt the workflow from intake to analysis, fixing the data model first, then adding tracking, templates, metadata, and forecasting to enable scalable operations.

  • Fixed the Benchling data model so sample lineage held together

  • Added unique IDs that follow each sample through the whole pipeline

  • Built automated sample sheets to remove copy-paste errors for a variety of sequencers including MiSeq, NextSeq, and NovaSeqs

  • Filled in the missing steps in the process

  • Enabled data ingestion directly from instruments

  • Created reusable templates for every team

  • Added metrics to enable forecasting runs, resourcing, and timelines



Outcome

Our solution became a database infrastructure the whole company uses, with errors gone and capacity the team can actually plan around.

  • 60+ scientists now submit through one standard process

  • Copy-paste and formatting errors eliminated

  • Fewer tasks to manage with plate-based tracking

  • Up to 7 instruments integrated in tracked workflows

  • Reliable forecasting for runs, resourcing, and budget



Facing a similar challenge?


bottom of page